Research in this U19 Program is dependent on a system of central, standardized, and innovative analyses of West Nile virus (WNV) infection in cultured cells and in mice. The Virology Core is designed to meet these needs and standards and to provide infrastructure support for conducting WNV infections and virologic analysis for all five research projects of the Program. The Virology Core will be directed by Dr. Yueh-Ming Loo, an experienced virologist, biosafety expert, and a professional in the use of mice for virus infection studies. The Virology core will 1) Produce, conduct quality control, and conduct studies of centralized virus stocks used by the Program, 2) Coordinate and conduct all mouse infection studies within the Program, 3) Conduct in vitro and in vivo virologic analyses for the Program, and 4) Conduct and coordinate biosafety training of the Program staff. The Virology Core will be located in a centralized facility containing a suite of biosafety rooms for tissue culture and infected animal housing under and work under biosafety level 3 practices. The Core will work closely with Project Leaders and staff to design infection studies and conduct virologic analysis in support of the proposed studies. The Core will provide services of virus and virus product quantification, virus construction and characterization, serologic analyses, molecular diagnostic and quantification analyses, in vitro and in vivo infection support and analysis, and animal monitoring, clinical scoring, and the harvesting and possessing of tissues and cell samples. The Virology Core will interface with the Administrative Core to maintain records and training of personnel, prepare reports, and to communicate with Program staff.

Public Health Relevance

Reliable virologic analyses are essential for understanding mechanisms of immune control of virus infection. The Virology Core wills serve as the central and essential facility to conduct virologic and infection analyses within the proposed studies of the U19 Program, and will contribute to a greater understanding of flavivirus/host interactions that control infection and immunity.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program--Cooperative Agreements (U19)
Project #
5U19AI083019-04
Application #
8375815
Study Section
Special Emphasis Panel (ZAI1-BDP-I)
Project Start
Project End
Budget Start
2012-05-01
Budget End
2013-04-30
Support Year
4
Fiscal Year
2012
Total Cost
$185,874
Indirect Cost
$66,724
Name
University of Washington
Department
Type
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
Bekerman, Elena; Neveu, Gregory; Shulla, Ana et al. (2017) Anticancer kinase inhibitors impair intracellular viral trafficking and exert broad-spectrum antiviral effects. J Clin Invest 127:1338-1352
Daniels, Brian P; Jujjavarapu, Harsha; Durrant, Douglas M et al. (2017) Regional astrocyte IFN signaling restricts pathogenesis during neurotropic viral infection. J Clin Invest 127:843-856
Da Costa, Andreia; Garza, Esteban; Graham, Jessica B et al. (2017) Extrinsic MAVS signaling is critical for Treg maintenance of Foxp3 expression following acute flavivirus infection. Sci Rep 7:40720
Gorman, Jacquelyn A; Hundhausen, Christian; Errett, John S et al. (2017) The A946T variant of the RNA sensor IFIH1 mediates an interferon program that limits viral infection but increases the risk for autoimmunity. Nat Immunol 18:744-752
Jagger, Brett W; Miner, Jonathan J; Cao, Bin et al. (2017) Gestational Stage and IFN-? Signaling Regulate ZIKV Infection In Utero. Cell Host Microbe 22:366-376.e3
Daniels, Brian P; Snyder, Annelise G; Olsen, Tayla M et al. (2017) RIPK3 Restricts Viral Pathogenesis via Cell Death-Independent Neuroinflammation. Cell 169:301-313.e11
Li, Junwei; Baird, Madison A; Davis, Michael A et al. (2017) Dramatic enhancement of the detection limits of bioassays via ultrafast deposition of polydopamine. Nat Biomed Eng 1:
Luo, Huanle; Winkelmann, Evandro; Xie, Guorui et al. (2017) MAVS Is Essential for Primary CD4+ T Cell Immunity but Not for Recall T Cell Responses following an Attenuated West Nile Virus Infection. J Virol 91:
Tajfirouz, Deena; West, Devin M; Yin, Xiao-Tang et al. (2017) CXCL9 compensates for the absence of CXCL10 during recurrent Herpetic stromal keratitis. Virology 506:7-13
Green, Richard; Wilkins, Courtney; Thomas, Sunil et al. (2017) Oas1b-dependent Immune Transcriptional Profiles of West Nile Virus Infection in the Collaborative Cross. G3 (Bethesda) 7:1665-1682

Showing the most recent 10 out of 120 publications